Triple

T5114894
Position Surface form Disambiguated ID Type / Status
Subject Memantine E115307 entity
Predicate targets P860 FINISHED
Object NMDA receptor
The NMDA receptor is a glutamate-activated ion channel in the brain that plays a key role in synaptic plasticity, learning, and memory, and is implicated in various neurological and psychiatric disorders.
E494104 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: NMDA receptor | Statement: [Memantine, targets, NMDA receptor]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: NMDA receptor
Context triple: [Memantine, targets, NMDA receptor]
  • A. memantine
    Memantine is a medication that helps manage symptoms of moderate to severe Alzheimer's disease by modulating glutamate activity in the brain.
  • B. CB1 receptor
    The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
  • C. hippocampus
    The hippocampus is a key brain structure involved in forming and retrieving memories, spatial navigation, and regulating emotional responses.
  • D. CB2 receptor
    The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
  • E. Hodgkin–Huxley model
    The Hodgkin–Huxley model is a mathematical description of how action potentials in neurons are initiated and propagated through voltage-gated ion channels in the cell membrane.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: NMDA receptor
Triple: [Memantine, targets, NMDA receptor]
Generated description
The NMDA receptor is a glutamate-activated ion channel in the brain that plays a key role in synaptic plasticity, learning, and memory, and is implicated in various neurological and psychiatric disorders.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: NMDA receptor
Target entity description: The NMDA receptor is a glutamate-activated ion channel in the brain that plays a key role in synaptic plasticity, learning, and memory, and is implicated in various neurological and psychiatric disorders.
  • A. memantine
    Memantine is a medication that helps manage symptoms of moderate to severe Alzheimer's disease by modulating glutamate activity in the brain.
  • B. CB1 receptor
    The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
  • C. hippocampus
    The hippocampus is a key brain structure involved in forming and retrieving memories, spatial navigation, and regulating emotional responses.
  • D. CB2 receptor
    The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
  • E. Hodgkin–Huxley model
    The Hodgkin–Huxley model is a mathematical description of how action potentials in neurons are initiated and propagated through voltage-gated ion channels in the cell membrane.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd4441d1648190a54a533895041987 completed March 20, 2026, 12:57 p.m.
NER Named-entity recognition batch_69bd75ce6044819094166aebf0688665 completed March 20, 2026, 4:29 p.m.
NED1 Entity disambiguation (via context triple) batch_69bebaadfaac8190aa0407196e5c4c20 completed March 21, 2026, 3:35 p.m.
NEDg Description generation batch_69bebb1a4370819085bcbe73a0b8c68e completed March 21, 2026, 3:36 p.m.
NED2 Entity disambiguation (via description) batch_69bebcf63784819097be14bb7dcbf4d9 completed March 21, 2026, 3:44 p.m.
Created at: March 20, 2026, 1:41 p.m.